Revance Therapeutics, Inc.
H‑1B Sponsor Verified
Yes. Revance Therapeutics, Inc. filed 52 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2019–2026, including 2 so far in 2026. The average H-1B salary is $137,081 and the most sponsored role is Devops Engineer.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Apr 16, 2026.
LinkedIn ↗Latest Year Filings
2
In 2026
↗ Filter by year
Total H‑1B Filings
52
Since 2020
↗ View records
Avg Annual Salary
$137,081
All years combined
↗ View chart
Top Role
Devops Engineer
↗ Click to filter
Filing trend
H‑1B filings by year for Revance Therapeutics, Inc.
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 2 | $108,056 |
| 2025 | 12 | $157,507 |
| 2024 | 16 | $131,688 |
| 2023 | 8 | $132,875 |
| 2022 | 3 | $149,667 |
| 2021 | 4 | $133,426 |
| 2020 | 6 | $124,053 |
| 2019 | 1 | $125,000 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary